Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in HairTransplantation

Sohag University

Status: Not yet enrolling

Conditions: Androgenic Alopecia

Treatments: Procedure: hair transplantation

Study type: Interventional

Funder types: Other

Identifiers

NCT07287579

Soh-Med--25-11-1MD

Details and patient eligibility

About

• To compare the efficacy of platlet rich plasma and Nanofat injection as adjuvant therapies with FUE hair transplantation in improving graft survival rate,
• To measure hair density and thickness postoperatively using dermoscopy or trichoscopy.
• To evaluate patient satisfaction and photographic assessment by blinded evaluators.
• To assess any adverse effects or complications related to each modality

Full description

• Ideal candidates for hair transplantation typically present with a clear, stable pattern of hair loss, characterized by at least 50% thinning or balding in 1 or more areas. The scalp must be healthy, with donor hair of good quality and quantity. Patients must have realistic expectations and be free of medical conditions that compromise surgical outcomes. The safe donor zone is located in the mid-occipital region between the upper and lower occipital protuberances, typically containing 65 to 85 follicular units/cm²
• Intra-operative injection of PRP is beneficial in giving faster density, reducing the catagen loss of transplanted hair, early recovery of the skin, the faster appearance of new anagen hair in FUE hair transplantation.
• This study compares the effects of PRP and Nano fat as adjuvants in Androgenic alopecia patients undergoing FUE hair transplantation.
• Nanofat contain stem cells supposed to improve the results of FUE hair transplantation , but the question that we hope to answer at the end of our study which one we recommend as an adjuvant therapy PRP or Nano fat?

Enrollment: 30 estimated patients

Sex: Male

Ages: 20 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 1. Male patients with stable androgenic alopecia more than 2 years. 2. Age 20-50 years 3. No recent medical hair loss treatments.

Exclusion criteria

• 1. Active scalp infections or scarring alopecia. 2. Systemic diseases affecting wound healing. 3. Platelet disorders or anticoagulant use. 4. Smoking or heavy alcohol intake

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

30 participants in 3 patient groups

group a

Experimental group

Description:

hair transplantation done alone without platelet rich plasma or nanofat injection

Treatment:

Procedure: hair transplantation

group b

Experimental group

Description:

we do injection of platelet rich plasma with hair transplantation

Treatment:

Procedure: hair transplantation

group c

Experimental group

Description:

we do injection of nanofat with hair transplantation

Treatment:

Procedure: hair transplantation